Faz Chowdhury
CEO
Faz Chowdhury originally trained as a pharmaceutical scientist, and subsequently completed a Masters in Microsystems and Nanotechnology at Cranfield University, and Doctorate at the University of Oxford on nano-drug delivery. His experience in the Pharmaceutical Industry spans product development, manufacturing, and technical and corporate management. He has numerous granted and pending patents in the field of drug delivery devices, and formulations. He has authored chapters on Pharmaceutical Nanosystems (Wiley, 2008), and Nano-biosciences (Elsevier, 2010), and serves on the Board of Medilink East Midlands.
Julie Pomeroy
Director of Finance
Julie is a physics graduate of Birmingham University who began her professional career with Robson Rhodes, qualifying as a Chartered Accountant in 1980. After qualifying as an associate of the Chartered Institute of Taxation, she worked for Arthur Andersen and Price Waterhouse and subsequently moved into the commercial sector in the early 1990s, as Group Tax Manager and subsequently Director of Corporate Finance for a utility company. She also qualified as an associate of the Institute of Corporate Treasurers . Julie also served as the Chief Financial Officer of Weston Medical, a drug delivery company, and subsequently Group FD at Carter & Carter Group. She has led two full list flotations on the London Stock Exchange, and is also a Chartered Director. Professor Karrar Khan
Director of Product Development
Professor Khan has over 35 years experience of drug discovery, pharmaceutical development, registration and managing pharmaceutical scientists. His experience includes 20 years as Head of Pharmaceutical Development for Boots Pharmaceuticals and Knoll and two years as Director for OSI where he managed their pharmaceutical development, analytical operations and DMPK. His expertise range from development for phase 1 to phase 3- 4 and significant experience of bringing prescription and OTC products to market on a global level (and has contributed to the registration and launch of over 60 pharmaceutical products). He is a Qualified person under the EC quality assurance directive. David Scott
Director of Commercial Development and Licensing
David Scott is a trained chemist with over 35 years experience in the Pharmaceutical Industry spanning deal brokering, marketing, strategic planning, finance, business development and acquisitions. He is a skilled negotiator who has closed a number of major deals for inward and outward licensing for pharmaceutical products, delivery systems and technologies. He has also provided licensing training for a number of multinational pharma companies and training organisations and has published widely, (he is the author of the best-selling report, "Scrip’s Practical Guide to Pharmaceutical Licensing”). David is also an accredited “Certified Licensing Professional”. Dr Richard Toon
Technical and Business Development Manager
Dr. Richard Toon is a chartered chemist who originally trained as a synthetic chemist and more recently trained in law. He has over 20 years of experience within pharmaceutical drug development including a number of years supervising 'blue skies' research projects for potential commercial exploitation within two large multinational Pharmaceutical Companies in the UK. More recently his career has focused on commercial law activities, such as contract negotiation and intellectual property issues, and business development. He has completed a number of large scale grant applications for industrial research, and is author of numerous publications pertaining to pharmaceutical development, and is also a Fellow of the Royal Society of Chemistry. |
MANAGEMENT